My HPRA: Register

IBANDRONIC ACID LICONSA

150 Base Milligrams Film Coated Tablet

Laboratorios LICONSA, S.A.PA1239/013/001

SPC: DATE OF REVISION OF THE TEXT

09 Nov 2016 - 30 Nov 2016	30 Nov 2016 - Present
October 2016	November 2016

« Back

Follow medicine

Print

Latest Changes to Medicine Info & SPC

30 Nov 2016
SPC: DATE OF REVISION OF THE TEXT
30 Nov 2016
SPC: DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION
30 Nov 2016
SPC: Special precautions for disposal and other handling
30 Nov 2016
SPC: Preclinical safety data
30 Nov 2016
SPC: Pharmacokinetic properties
30 Nov 2016
SPC: Pharmacodynamic properties
30 Nov 2016
SPC: Overdose
30 Nov 2016
SPC: Effects on ability to drive and use machines
30 Nov 2016
SPC: Contraindications
30 Nov 2016
SPC: Posology and method of administration
30 Nov 2016
SPC: Therapeutic Indications
16 Nov 2016
SPC: Undesirable effects
16 Nov 2016
SPC: Special warnings and precautions for use
09 Nov 2016
SPC: DATE OF REVISION OF THE TEXT
09 Nov 2016
SPC: MARKETING AUTHORISATION NUMBER
09 Nov 2016
SPC: Undesirable effects
09 Nov 2016
SPC: Fertility, pregnancy and lactation
09 Nov 2016
SPC: Interaction with other medicinal products and other forms of interaction
09 Nov 2016
SPC: Special warnings and precautions for use
29 Mar 2016
SPC: DATE OF REVISION OF THE TEXT
29 Mar 2016
SPC: Pharmacodynamic properties
29 Mar 2016
SPC: Undesirable effects
29 Mar 2016
SPC: Special warnings and precautions for use

Please note changes to the medicine information and summary of product characteristics are only available from the 19/05/2015 onwards. Changes made before this date aren't available online.

Important information regarding cookies and the HPRA

By using this website, you consent to the use of cookies in accordance with the HPRA Cookie Policy.
For more information on cookies, see our cookie policy.

Click here to accept the cookie policy and hide this message